Gastrointestinal Cancers

Opdivo was approved by the FDA for use if disease persisted after neoadjuvant chemoradiotherapy in these patients, which is “exciting news,” as patients would typically undergo surveillance when this occurred.

Based on findings from the KEYNOTE-811 trial, the FDA approved Keytruda for the treatment of patients with locally advanced unresectable or metastatic HER2-positive gastric or gastroesophageal junction adenocarcinoma in combination with trastuzumab and chemotherapy.

The FDA has approved the combination of Opdivo (nivolumab) plus certain types of chemotherapy for the treatment of patients with advanced or metastatic gastric cancer, gastroesophageal junction (GEJ) cancer, and esophageal adenocarcinoma, making it the first frontline immunotherapy agent approved in this space.

In clinical trials, Opdivo in combination with chemotherapy improved overall survival and progression-free survival compared to chemotherapy alone.

Theresa Germano sat down with HEAL® to discuss her journey with cancer, how her daughter became her hero and how listening to her body benefited her in the end.

For patients with gastric/ gastroesophageal cancer, treatment with Bavencio after chemotherapy shows favorable safety, but no overall survival improvement.

The priority review will focus on Opdivo with chemotherapy for the treatment several gastrointestinal cancers, which has recently become a rising area in novel treatment development.

The Food and Drug Administration approved Enhertu to treat adults with locally advanced or metastatic HER2-positive gastroesophageal or gastric cancer who have previously received a trastuzumab-based treatment regimen.

The FDA granted a priority review to the supplemental biologics license application for the combination of Keytruda and chemotherapy for the firstline treatment of locally advanced unresectable or metastatic esophageal and gastroesophageal junction cancer.

I am a nurse practitioner and a professor. But my best job was being a daughter and caregiver to the most wonderful mother anyone could ever have.

Join us for our Inaugural 1st Hope Webcast on surgical strategies for Stage IV stomach cancer.

Cancer makes your mind wander in many strange directions. If ever you wanted to know what an emotional rollercoaster really felt like, get on the cancer coaster and go for a ride.

Patients, caregivers, and families to gain virtual access to the latest topics in gastric cancer research from oncology experts.

In an effort to combat hereditary stomach cancer, it takes the entire family to help understand what it takes.

Study findings showed that eradicating Helicobacter pylori infection reduced the risk of developing gastric cancer by 73% in those with a first-degree relative with the disease, compared with individuals in whom infection was persistent.

The incidence of colorectal and gastric cancers has risen for younger patients, and many of them share ethnic and socioeconomic disparities as well.

After beating stomach cancer, a grandmother transformed herself into a competitive amateur athlete to stay active and healthy.

A new study suggests the common pill could help prevent deaths from cancer, but it’s not without it's share of side effects.

After one woman’s father received a terminal stomach cancer diagnosis, she turned to Debbie’s Dream Foundation: Curing Stomach Cancer for information and guidance.

November is Stomach Cancer Awareness Month. Here's a round up of the latest news and updates in this disease space.

Best-selling author V. Gilbert Beers surprises doctors and proves “age is just a number.”

After turning to Debbie’s Dream, one woman shares how receiving support from fellow caregivers of loved ones with stomach cancer led to her to call on home health nurses throughout her husband’s journey.

A nearly 10-year stomach cancer survivor works with Debbie’s Dream Foundation to raise disease awareness and raise money for a cure.

Patients with gastrointestinal cancers should be aware of specific side effects that might arise — and ways to prevent or ease them.

An oncology dietitian offered advice on how to improve appetite and eat healthy before, during and after treatment for gastrointestinal cancers.

Cancer can indeed be a numbers game, but I am no way just a statistic — no one is. This journey has given me a newfound perspective on life and the amazing work that Stand Up To Cancer does.

The Food and Drug Administration approved Kanjinti, a biosimilar to the US-licensed Herceptin, marking it the fifth of its kind.

Emerging facts about the genetics that drive gastric cancer are leading to new treatments for the disease.

Overall survival in metastatic gas­tric or gastroesophageal junction cancer improved significantly in patients who received the oral combination chemo­therapy Lonsurf regardless of whether they’d had a gastrectomy.